1. RESEARCH SCOPE & METHODOLOGY
1.1. STUDY OBJECTIVES
1.2. SCOPE OF STUDY
1.3. METHODOLOGY
1.4. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY
2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW

3. MARKET DYNAMICS
3.1. DEVELOPMENT OF ARTIFICIAL INTELLIGENCE IN HEALTHCARE
3.2. MARKET DEFINITION
3.3. KEY DRIVERS
3.3.1. RISE OF BIG DATA IN HEALTHCARE INDUSTRY
3.3.2. EMERGENCE OF PERSONALIZED MEDICINE IN TESTS FOR CLINICAL DECISION MAKING
3.3.3. INCREASING USE OF AI IN GENETICS
3.3.4. AI CREATING A REAL-TIME MONITORING SYSTEM
3.3.5. HEALTHCARE WEARABLES PLAYING AN IMPORTANT ROLE IN MONITORING
3.4. KEY RESTRAINTS
3.4.1. SLOW ADOPTION OF AI BASED TECHNOLOGIES
3.4.2. AMBIGUOUS REGULATORY GUIDELINES FOR MEDICAL SOFTWARE
3.4.3. CHALLENGE TO MAINTAIN DATA SECURITY
3.4.4. LACK OF USABLE DATA IN HEALTHCARE

4. KEY ANALYTICS
4.1. KEY INVESTMENT INSIGHTS
4.2. PORTER'S FIVE FORCE ANALYSIS
4.2.1. BUYER POWER
4.2.2. SUPPLIER POWER
4.2.3. SUBSTITUTION
4.2.4. NEW ENTRANTS
4.2.5. INDUSTRY RIVALRY
4.3. OPPORTUNITY MATRIX
4.4. VENDOR LANDSCAPE
4.5. VALUE CHAIN ANALYSIS
4.5.1. DATA WAREHOUSE
4.5.2. ARTIFICIAL INTELLIGENCE (AI) ANALYSIS
4.5.3. SOFTWARE DEVELOPMENT
4.6. KEY BUYING CRITERIA
4.6.1. APPLICATION
4.6.2. TECHNOLOGY
4.6.3. INTEGRATION WITH EXISTING INFRASTRUCTURE
4.7. REGULATORY FRAMEWORK

5. MARKET BY OFFERINGS
5.1. HARDWARE
5.2. SOFTWARE
5.3. SERVICES

6. MARKET BY TECHNOLOGY
6.1. DEEP LEARNING
6.2. QUERYING METHOD
6.3. NATURAL LANGUAGE PROCESSING
6.4. CONTEXT AWARE PROCESSING

7. MARKET BY END-USER
7.1. ACOS AND MCOS
7.2. PATIENTS
7.3. PAYERS
7.4. PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
7.5. PROVIDERS

8. MARKET BY APPLICATION
8.1. REAL-TIME MONITORING
8.2. PRECISION MEDICINE
8.3. PERSONAL HEALTH AND NURSING ASSISTANTS
8.4. DRUG DEVELOPMENT AND DISCOVERY
8.5. ROBOT-ASSISTED SURGERY
8.6. ADMINISTRATIVE WORKFLOW ASSISTANCE
8.7. CLINICAL TRIALS
8.8. DIAGNOSTIC AND CLINICAL DECISION SUPPORT
8.9. OTHERS

9. GEOGRAPHICAL ANALYSIS
9.1. EUROPE
9.1.1. UNITED KINGDOM
9.1.2. GERMANY
9.1.3. FRANCE
9.1.4. ITALY
9.1.5. RUSSIA
9.1.6. BELGIUM
9.1.7. POLAND
9.1.8. REST OF EUROPE

10. COMPANY PROFILES
10.1. DEEP GENOMICS INC
10.2. ENLITIC INC
10.3. GE HEALTHCARE
10.4. GENERAL VISION INC
10.5. GOOGLE
10.6. IBM CORPORATION
10.7. ICARBONX
10.8. INTEL CORPORATION
10.9. MICROSOFT CORPORATION
10.10. NEXT IT CORPORATION
10.11. NVIDIA CORPORATION
10.12. ONCORA MEDICAL
10.13. RECURSION PHARMACEUTICALS INC
10.14. STRYKER CORPORATION
10.15. WELLTOK INC